9 completed, 1 recruiting. 3 Not applicable, 3 Phase 4, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Recruiting 1 |
| Phase 4 | 3 | Completed 3 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Influenza: new trials by email Literature Review of Influenza trials Research Report on Influenza
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-specific Effects of FLU-MMR Vaccines in Adults Influenza, MMR vaccines, Placebo - COVID-19 | Early Phase 1 | Completed | Radboud University Medical Center | 638 | 2021-06-01 | 2024-10-02 |
| Adjuvanted Influenza Vaccination Year 2 Follow-On Survey Influenza - Influenza, Influenza-like Illness | Completed | Insight Therapeutics, LLC | 598 | 2018-07-13 | 2023-03-16 | |
| Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting Influenza - Human Influenza | Completed | University of Zurich | 700 | 2016-01-01 | 2017-10-31 | |
| Influenza Immunization in Adults Over Age 75 Influenza - Influenza, Immunization | Not applicable | Recruiting | Johns Hopkins University | 1025 | 2014-03-01 | 2026-03-16 |
| Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons Vaccination with Fluval AB influenza vaccine - Influenza | Phase 4 | Completed | Fluart Innovative Vaccine Ltd, Hungary | 121 | 2011-07-01 | 2012-05-21 |
| Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children Vaccination with FLUVAL P - Influenza | Not applicable | Completed | Fluart Innovative Vaccine Ltd, Hungary | 10 | 2009-09-01 | 2012-05-21 |
| Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine Vaccination with Fluval P and Fluval AB influenza vaccines, Vaccination with Fluval P monovalent influenza vaccine - Influenza | Not applicable | Completed | Fluart Innovative Vaccine Ltd, Hungary | 355 | 2009-08-01 | 2012-05-21 |
| Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months Influenza - Influenza | Phase 4 | Completed | Novartis | 270 | 2005-10-01 | 2006-09-14 |
| Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines Influenza - Influenza | Phase 3 | Completed | GlaxoSmithKline | 1847 | 2005-10-01 | 2017-01-18 |
| Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV Hepatitis A, Hepatitis B, Influenza - HIV | Phase 4 | Completed | Hospital Clinic of Barcelona | 26 | 2003-04-01 | 2006-05-24 |
Influenza, Human (8) · Infections (2) · COVID-19 (1)
Fluart Innovative Vaccine Ltd, Hungary (3) · GlaxoSmithKline (1) · Hospital Clinic of Barcelona (1) · Insight Therapeutics, LLC (1) · Johns Hopkins University (1) · Novartis (1) · Radboud University Medical Center (1) · University of Zurich (1)
Hungary (3) · United States (3) · Brazil (1) · Finland (1) · Spain (1) · Switzerland (1)
Anna Osi, Dr. (1) · Ferenc Tamas, MD (1) · H. Edward Davidson, PharmD, MPH (1) · Mihai Netea, PhD (1) · Pedro Gozalo, Phd (1) · Sean Leng (1) · Stefan Gravenstein, MD, MPH (1)
PMID 20018367, PMID 21285532, PMID 23121249, PMID 24820104, PMID 27427877, PMID 31113375, PMID 33239124